Intezer

Intezer was founded in Israel in 2015 by Itai Tevet, Alon Cohen (also a founder of CyberArk), and Roy Halevi, and operates with U.S. commercial headquarters in New York alongside its Israeli engineering base. The company’s core premise is that essentially all software, malicious or legitimate, is built from previously written code, and that detecting reused code fragments is a more durable signal than matching full-file hashes or signatures that attackers can trivially alter.

Its “genetic malware analysis” technology decomposes binaries into code fragments (referred to internally as “genes”) and compares them against a large database of known-good and known-malicious code, even when only small fragments match. This allows classification of previously unseen samples by their code lineage — attributing a new sample to a known malware family or threat actor’s toolkit based on shared code ancestry, similar in concept to (though independently developed from) other genomic-style malware analysis approaches in the category.

Intezer raised a $15 million Series B round from investors including OpenView, Intel Capital, and Samsung Next, with total disclosed funding of roughly $60 million; it has since extended its technology from static file analysis into fileless and memory-based threat detection.